TAGS sbarro health research organization

A month ago Professor Giovan Giacomo Giordano, the distinguished medical pathologist who has devoted over sixty years of his life in the field of cancer research and teaching Anatomic and Pathological Histology at the University of Naples, passed away. Author and coauthor of over three hundred publications, has spent most of his scientific research to study: the interaction between chemical... read

On October 15 and 16, 2010, the VII "Wine and Health" Conference was held in Montalcino at the Theatre of the Astrusi The event, sponsored by the Wine and Health Association in collaboration with the Municipality of Montalcino and the Consorzio del Vino Brunello, addressed this important and timely issue: the wine and its health effects. The Mayor of Montalcino Maurizio Buffi, the President of... read

Saturday, January 15 at 11:00 am at the Bottiglieri Hall of the Province of Salerno, the "New Tumor Registry of Salerno" was presented in the presence of: the oncologist Dr. Frank Romeo; the managing directors of the hospitals of the province; the directors of the healthcare district; the directors of ASL Salerno Unica; prof. Giulio Tarro; the Municipal Councillors for healthcare policies;... read

(February 24) – PHILADELPHIA -- Despite innumerable studies on lung cancer, many aspects of the disease have yet to be understood, including the role played by the retinoblastoma-related protein Rb2/p130 in the evolution of the disease. In a new study, researchers from the Sbarro Health Research Organization Center for Biotechnology Research (SHRO), a cancer, cardiovascular and diabetes... read

Seven prestigious Italian-Americans, who have excelled in the fields of communication, business and medicine, were elected to the Board of Directors of the National Italian American Foundation's (NIAF) last March 11, 2011, during a meeting at the Wigwam Golf Resort & Spa in Litchfield Park, Arizona. The new NIAF "Board of Directors" elected members are: Maria Bartiromo, the CNBC network... read

A few days ago, the FDA (Food and Drug Administration, the American institution that controls food and drug safety) approved the use of Ipilimumab, a drug based on a monoclonal antibody, which has yielded encouraging results in the fight against melanoma. During the testing phase of this antibody, the survival of patients has increased significantly: it has almost doubled at one year, rising... read

In 1993, Antonio Giordano, M.D., Ph.D., founded the Sbarro Institute with a $1 million donation from Mario Sbarro, the Founder of the Sbarro restaurant chain, following Dr. Giordano’s discovery of the tumor suppressor gene pRb2. Initially named the Sbarro Institute, the research center was located at Thomas Jefferson University, where Dr. Giordano was a professor. When Dr. Giordano moved to... read

Inactivation of the retinoblastoma tumor suppressor protein (pRb) by phosphorylation triggers uncontrolled cell proliferation. Accordingly, activation of cyclin-dependent kinase (CDK)/cyclin complexes or downregulation of CDK inhibitors appears as a common event in human cancer. Now, a new study from the Sbarro Health Research Organization shows that Pin1 (protein interacting with NIMA (never... read